Cargando…

Hemodynamic trajectories and outcomes in patients with pulmonary arterial hypertension

The relative pulmonary to systemic pressure ratio (mean pulmonary arterial pressure/mean arterial pressure) has been proven to be valuable in cardiac surgery. Little is known on the prognostic value of baseline and trajectory of mean pulmonary arterial pressure/mean arterial pressure in pulmonary ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Amsallem, Myriam, Bagherzadeh, Shadi P., Boulate, David, Sweatt, Andrew J., Kudelko, Kristina T., Sung, Yon K., Feinstein, Jeffrey A., Fadel, Elie, Mercier, Olaf, Denault, Andre, Haddad, Francois, Zamanian, Roham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724418/
https://www.ncbi.nlm.nih.gov/pubmed/33335708
http://dx.doi.org/10.1177/2045894020941343
_version_ 1783620532255588352
author Amsallem, Myriam
Bagherzadeh, Shadi P.
Boulate, David
Sweatt, Andrew J.
Kudelko, Kristina T.
Sung, Yon K.
Feinstein, Jeffrey A.
Fadel, Elie
Mercier, Olaf
Denault, Andre
Haddad, Francois
Zamanian, Roham
author_facet Amsallem, Myriam
Bagherzadeh, Shadi P.
Boulate, David
Sweatt, Andrew J.
Kudelko, Kristina T.
Sung, Yon K.
Feinstein, Jeffrey A.
Fadel, Elie
Mercier, Olaf
Denault, Andre
Haddad, Francois
Zamanian, Roham
author_sort Amsallem, Myriam
collection PubMed
description The relative pulmonary to systemic pressure ratio (mean pulmonary arterial pressure/mean arterial pressure) has been proven to be valuable in cardiac surgery. Little is known on the prognostic value of baseline and trajectory of mean pulmonary arterial pressure/mean arterial pressure in pulmonary arterial hypertension. Patients with confirmed idiopathic, familial, drug and toxins, or connective tissue disease-related pulmonary arterial hypertension and at least one complete right heart catheterization were included and prospectively followed-up for 5.9 ± 4.03 years. Correlates of the primary end point (i.e. death or lung transplant need) during follow-up were determined using Cox regression modeling. Results showed that among the 308 patients included, 187 had at least one follow-up catheterization (median time between catheterizations: 2.16 (1.16–3.19) years). In the total cohort (mean age 47.3 ± 14.9 years, 82.8% of female and 58.1% in New York Heart Association class 3 or 4), mean pulmonary arterial pressure/mean arterial pressure (1.38 (1.07–1.77)) was associated with outcome (p = 0.01). Mean pulmonary arterial pressure/mean arterial pressure was incremental to a basic model (including right atrial pressure, systolic blood pressure, New York Heart Association class 3 or 4, and connective tissue disease) for outcome prediction, while mean pulmonary arterial pressure was not. In the 187 patients with a follow-up catheterization, both delta mean pulmonary arterial pressure and delta mean pulmonary arterial pressure/mean arterial pressure were associated with outcome (1.32 (1.11–1.58) and 1.31 (1.1–1.57) respectively, p < 0.01). Mean pulmonary arterial pressure and mean pulmonary arterial pressure/mean arterial pressure were both incremental to the basic model, while worsening in mean pulmonary arterial pressure or mean pulmonary arterial pressure/mean arterial pressure did not reach significance. In conclusion, mean pulmonary arterial pressure/mean arterial pressure at baseline prognosticates long-term outcome with a significant, albeit modest, incremental value to basic variables.
format Online
Article
Text
id pubmed-7724418
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-77244182020-12-16 Hemodynamic trajectories and outcomes in patients with pulmonary arterial hypertension Amsallem, Myriam Bagherzadeh, Shadi P. Boulate, David Sweatt, Andrew J. Kudelko, Kristina T. Sung, Yon K. Feinstein, Jeffrey A. Fadel, Elie Mercier, Olaf Denault, Andre Haddad, Francois Zamanian, Roham Pulm Circ Original Research Article The relative pulmonary to systemic pressure ratio (mean pulmonary arterial pressure/mean arterial pressure) has been proven to be valuable in cardiac surgery. Little is known on the prognostic value of baseline and trajectory of mean pulmonary arterial pressure/mean arterial pressure in pulmonary arterial hypertension. Patients with confirmed idiopathic, familial, drug and toxins, or connective tissue disease-related pulmonary arterial hypertension and at least one complete right heart catheterization were included and prospectively followed-up for 5.9 ± 4.03 years. Correlates of the primary end point (i.e. death or lung transplant need) during follow-up were determined using Cox regression modeling. Results showed that among the 308 patients included, 187 had at least one follow-up catheterization (median time between catheterizations: 2.16 (1.16–3.19) years). In the total cohort (mean age 47.3 ± 14.9 years, 82.8% of female and 58.1% in New York Heart Association class 3 or 4), mean pulmonary arterial pressure/mean arterial pressure (1.38 (1.07–1.77)) was associated with outcome (p = 0.01). Mean pulmonary arterial pressure/mean arterial pressure was incremental to a basic model (including right atrial pressure, systolic blood pressure, New York Heart Association class 3 or 4, and connective tissue disease) for outcome prediction, while mean pulmonary arterial pressure was not. In the 187 patients with a follow-up catheterization, both delta mean pulmonary arterial pressure and delta mean pulmonary arterial pressure/mean arterial pressure were associated with outcome (1.32 (1.11–1.58) and 1.31 (1.1–1.57) respectively, p < 0.01). Mean pulmonary arterial pressure and mean pulmonary arterial pressure/mean arterial pressure were both incremental to the basic model, while worsening in mean pulmonary arterial pressure or mean pulmonary arterial pressure/mean arterial pressure did not reach significance. In conclusion, mean pulmonary arterial pressure/mean arterial pressure at baseline prognosticates long-term outcome with a significant, albeit modest, incremental value to basic variables. SAGE Publications 2020-12-06 /pmc/articles/PMC7724418/ /pubmed/33335708 http://dx.doi.org/10.1177/2045894020941343 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research Article
Amsallem, Myriam
Bagherzadeh, Shadi P.
Boulate, David
Sweatt, Andrew J.
Kudelko, Kristina T.
Sung, Yon K.
Feinstein, Jeffrey A.
Fadel, Elie
Mercier, Olaf
Denault, Andre
Haddad, Francois
Zamanian, Roham
Hemodynamic trajectories and outcomes in patients with pulmonary arterial hypertension
title Hemodynamic trajectories and outcomes in patients with pulmonary arterial hypertension
title_full Hemodynamic trajectories and outcomes in patients with pulmonary arterial hypertension
title_fullStr Hemodynamic trajectories and outcomes in patients with pulmonary arterial hypertension
title_full_unstemmed Hemodynamic trajectories and outcomes in patients with pulmonary arterial hypertension
title_short Hemodynamic trajectories and outcomes in patients with pulmonary arterial hypertension
title_sort hemodynamic trajectories and outcomes in patients with pulmonary arterial hypertension
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724418/
https://www.ncbi.nlm.nih.gov/pubmed/33335708
http://dx.doi.org/10.1177/2045894020941343
work_keys_str_mv AT amsallemmyriam hemodynamictrajectoriesandoutcomesinpatientswithpulmonaryarterialhypertension
AT bagherzadehshadip hemodynamictrajectoriesandoutcomesinpatientswithpulmonaryarterialhypertension
AT boulatedavid hemodynamictrajectoriesandoutcomesinpatientswithpulmonaryarterialhypertension
AT sweattandrewj hemodynamictrajectoriesandoutcomesinpatientswithpulmonaryarterialhypertension
AT kudelkokristinat hemodynamictrajectoriesandoutcomesinpatientswithpulmonaryarterialhypertension
AT sungyonk hemodynamictrajectoriesandoutcomesinpatientswithpulmonaryarterialhypertension
AT feinsteinjeffreya hemodynamictrajectoriesandoutcomesinpatientswithpulmonaryarterialhypertension
AT fadelelie hemodynamictrajectoriesandoutcomesinpatientswithpulmonaryarterialhypertension
AT mercierolaf hemodynamictrajectoriesandoutcomesinpatientswithpulmonaryarterialhypertension
AT denaultandre hemodynamictrajectoriesandoutcomesinpatientswithpulmonaryarterialhypertension
AT haddadfrancois hemodynamictrajectoriesandoutcomesinpatientswithpulmonaryarterialhypertension
AT zamanianroham hemodynamictrajectoriesandoutcomesinpatientswithpulmonaryarterialhypertension